Sarepta Therapeutics Inc (SRPT)

Operating return on assets (Operating ROA)

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating income	US$ in thousands	218,081	-267,824	-536,201	-449,710	-564,163
Total assets	US$ in thousands	3,963,170	3,264,580	3,128,370	3,147,970	2,984,720
Operating ROA		5.50%	-8.20%	-17.14%	-14.29%	-18.90%

December 31, 2024 calculation

Operating ROA = Operating income ÷ Total assets
= $218,081K ÷ $3,963,170K
= 5.50%

Based on the data provided, Sarepta Therapeutics Inc's operating return on assets (operating ROA) has shown fluctuations over the years:

1. As of December 31, 2020, the operating ROA was at -18.90%, indicating that for every dollar of assets, the company generated a loss of 18.90 cents from its operations.

2. By December 31, 2021, there was a slight improvement with the operating ROA decreasing to -14.29%, although it still remained negative, implying operational inefficiencies or challenges.

3. The trend continued into December 31, 2022, with the operating ROA at -17.14%, suggesting a decline in the company's ability to generate returns from its assets through its core operations.

4. However, by December 31, 2023, there was a notable improvement as the operating ROA increased to -8.20%. This indicated a positive shift, although the company was still not operating at a level of profitability commensurate with its assets.

5. The most significant change occurred by December 31, 2024, when the operating ROA turned positive at 5.50%. This shift indicated that Sarepta Therapeutics Inc was able to efficiently utilize its assets to generate a return from its operations, potentially showcasing improved operational performance or strategic changes.

In conclusion, the analysis of Sarepta Therapeutics Inc's operating ROA demonstrates a volatile performance over the years, with a gradual improvement in the company's ability to generate returns from its assets through its operational activities.